EVERESTOPharmaceuticals
Everest Organics Ltd — Cash Flow Statement
₹203.45
+2.44%
Everest Organics Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -10.80 Cr | 3.00 Cr | 4.88 Cr | -3.42 Cr | — |
| Issuance Of Capital Stock | 27.00 Cr | 0.00 | — | 0.00 | 0.00 |
| Capital Expenditure | -5.43 Cr | -13.09 Cr | -13.53 Cr | -17.15 Cr | — |
| End Cash Position | 6.09 Cr | 0.27 Cr | 0.27 Cr | 0.65 Cr | — |
| Beginning Cash Position | 0.27 Cr | 0.27 Cr | 0.65 Cr | 1.66 Cr | — |
| Changes In Cash | 5.82 Cr | -18000.00 | -0.38 Cr | -1.01 Cr | — |
| Financing Cash Flow | 16.36 Cr | -3.10 Cr | -2.65 Cr | 2.07 Cr | — |
| Interest Paid Cff | -5.19 Cr | -5.47 Cr | -3.31 Cr | -3.10 Cr | — |
| Net Common Stock Issuance | 27.00 Cr | 0.00 | — | 0.00 | 0.00 |
| Common Stock Issuance | 27.00 Cr | 0.00 | — | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -5.45 Cr | 2.37 Cr | 0.66 Cr | 5.17 Cr | — |
| Net Long Term Debt Issuance | -5.45 Cr | 2.37 Cr | 0.66 Cr | 5.17 Cr | — |
| Investing Cash Flow | -5.17 Cr | -13.00 Cr | -16.15 Cr | -16.82 Cr | — |
| Net Other Investing Changes | 1000.00 | -0.33 Cr | -2.25 Cr | 1.08 Cr | — |
| Interest Received Cfi | 0.26 Cr | 0.10 Cr | 0.03 Cr | 0.05 Cr | — |
| Net Intangibles Purchase And Sale | -1.85 Cr | 0.00 | — | — | — |
| Purchase Of Intangibles | -1.85 Cr | 0.00 | — | — | — |
| Net PPE Purchase And Sale | -3.58 Cr | -13.09 Cr | -13.53 Cr | -17.15 Cr | — |
| Purchase Of PPE | -3.58 Cr | -13.09 Cr | -13.53 Cr | -17.15 Cr | — |
| Operating Cash Flow | -5.38 Cr | 16.09 Cr | 18.42 Cr | 13.74 Cr | — |
| Taxes Refund Paid | 0.12 Cr | 0.02 Cr | — | — | — |
| Change In Working Capital | -12.53 Cr | 3.84 Cr | 10.85 Cr | 5.87 Cr | — |
| Change In Other Current Liabilities | -3.89 Cr | 6.23 Cr | 9.73 Cr | 13.15 Cr | — |
| Change In Other Current Assets | -3.08 Cr | 3.84 Cr | -1.42 Cr | -3.12 Cr | — |
| Change In Payable | -14.87 Cr | 15.56 Cr | 15.55 Cr | 22.36 Cr | — |
| Change In Prepaid Assets | 0.22 Cr | -0.67 Cr | — | — | — |
| Change In Inventory | -1.48 Cr | 2.97 Cr | -5.25 Cr | -8.57 Cr | — |
| Change In Receivables | 10.57 Cr | -24.08 Cr | -7.77 Cr | -17.95 Cr | — |
| Other Non Cash Items | 4.93 Cr | 5.37 Cr | 3.27 Cr | 3.05 Cr | — |
| Provisionand Write Offof Assets | 0.37 Cr | 0.34 Cr | — | — | — |
| Deferred Tax | -1.82 Cr | -0.03 Cr | -0.27 Cr | -0.12 Cr | — |
| Depreciation And Amortization | 5.96 Cr | 5.80 Cr | 4.47 Cr | 3.80 Cr | — |
| Depreciation | 5.96 Cr | 5.80 Cr | 4.47 Cr | 3.80 Cr | — |
| Pension And Employee Benefit Expense | 0.12 Cr | 0.16 Cr | — | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 0.04 Cr | -64000.00 | — | — | — |
| Net Income From Continuing Operations | -3.24 Cr | 0.61 Cr | 0.09 Cr | 1.14 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 4000.00 | 24000.00 | 1000.00 | -1000.00 |
| Dividends Received Cfi | — | 0.00 | -0.40 Cr | -0.80 Cr | -1.20 Cr |
| Net Investment Purchase And Sale | — | — | — | 0.00 | 0.00 |
| Purchase Of Investment | — | — | — | 0.00 | 0.00 |
| Sale Of PPE | — | — | — | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Everest Organics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.